Genetic Disease, X-Linked
2 clinical trials · Condition
◉ Watch Genetic Disease, X-Linked
| Record | Firm | Date |
|---|---|---|
| Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO) (NCT07608432) | Dyne Therapeutics | 2026-06-01 |
| Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes (NCT00001405) | National Institute of Allergy and Infectious Diseases (NIAID) | 1994-02-27 |
Track Genetic Disease, X-Linked automatically
Every clearance here is in the API, with alerts when new ones post.